Galectin Therapeutics Inc (GALT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.34B
EV to revenue ratio (TTM)
n/a
EV to ebitda
-4.04
Financial Performance
Revenue (TTM)
$0B
Gross profit (TTM)
$0B
EBITDA
n/a
Profitability
Operating margin (TTM)
<0.01%
Profit margin
<0.01%
Return on assets (TTM)
-64.20%
Return on equity (TTM)
-3,728.00%
Per Share Metrics
Revenue per share (TTM)
$0
EPS
-$0.43
Diluted EPS (TTM)
-$0.43
Book value
-$2.10
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
4.54
PEG ratio
0
Price to sales ratio (TTM)
n/a
Price to book ratio (TTM)
207.70
Growth
Quarterly earnings growth (YoY)
<0.01%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.50